Exchange and cooperation project between the Fourth Hospital of Hebei Medical University and members of tumor organizations such as ESMO

The Fourth Hospital of Hebei Medical University, also known as Hebei Cancer Hospital, is a comprehensive "Grade III Grade A" hospital that focuses on diagnosis and treatment of tumors, integrating medical treatment, teaching, scientific research, and preventive health care. The Hebei Cancer Center, Hebei Cancer Research Institute, Hebei Cancer Prevention and Control Office, Hebei Anti Cancer Association, and Hebei Sino Japanese Friendship Cancer Diagnosis Center are all located in our hospital. Basic Information: The hospital was founded in 1955 and now has two hospital areas, covering an area of 210 acres and a building area of 142000 square meters. There are 1863 open beds, over 4000 employees, and 64 clinical and medical technology departments. The personnel structure consists of 522 senior professional and technical personnel, including 19 experts who enjoy special allowances from the State Council, 13 outstanding experts under provincial management, 27 young and middle-aged experts with outstanding contributions in Hebei Province, 29 doctoral supervisors, 227 master's supervisors, and 209 personnel with doctoral degrees. Discipline construction: the Department of Critical Care Medicine, thoracic surgery, General Surgery, and Oncology are the national key clinical specialties Oncology is the province's strong characteristic discipline Respiratory Medicine, Gynecology, Oncology, Gastroenterology, Newborn, Anesthesiology, Pathology, Otolaryngology, Hematology, dermatology, Laboratory, Stomatology, Nephrology, Medical Imaging, Pediatrics are the province's key clinical specialties Obstetrics, Emergency Neurology and ophthalmology are key clinical training specialties in the province. Gastroenterology, Intensive Medicine, Pathology, Hematology, thoracic surgery, Anesthesiology, Radiotherapy, General Surgery, Medical Imaging, Obstetrics and Gynecology, Nephrology are provincial key disciplines, Oncology and Respiratory Medicine are provincial key development disciplines, oncogene Diagnosis, Prevention and Treatment Laboratory, and Hebei Province Key Research Office of Traditional Chinese Medicine for Chocking and Treatment are provincial key laboratories. The professional feature is the diagnosis and treatment of tumors, forming a comprehensive treatment system of surgery, radiotherapy, chemotherapy, immunotherapy, and combination of traditional Chinese and Western medicine. Especially in the diagnosis and treatment of esophageal cancer, 36000 cases have been completed so far, making it the hospital with the highest number of surgeries for this disease in the world and reaching the advanced level in China. Professional departments such as cardiology, reproduction, nephrology, respiration, and digestion are renowned in the province. The medical work hospital has a complete set of departments, which comprehensively diagnose and treat various systemic diseases such as internal, external, gynecological, and pediatric diseases. In recent years, hospitals have continuously improved their standardized diagnosis and treatment capabilities for common and frequently occurring diseases, comprehensively improved their early diagnosis, treatment, comprehensive intervention, and personalized comprehensive treatment capabilities, and improved their ability to handle critically ill and difficult patients. Obstetrics and gynecology focuses on the diagnosis and treatment of gynecological cervical cancer, ovarian cancer, and endometrial cancer, and is a large-scale gynecological tumor clinical base in northern China. Kehoe, Professor Sean, and Professor MorrisonJ have rich experience in the selection of neoadjuvant chemotherapy and surgery for ovarian cancer. Through learning and communication with them, they have achieved good results in initial surgery and standardized postoperative chemotherapy, improving postoperative quality of life. Ovarian cancer is the third most common gynecological malignancy after cervical cancer and endometrial cancer, and its mortality rate ranks first among gynecological malignancies. Ovarian cancer is primary in 90% to 95%, while the remaining 5% to 10% are metastatic. Ovarian cancer is the third most common gynecological malignancy after cervical and endometrial cancer, with the highest mortality rate among gynecological malignancies. Ovarian cancer is primary in 90% to 95%, while the remaining 5% to 10% are metastatic. The etiology of ovarian cancer is unknown, and its onset may be related to fertility, age, psychological factors, environmental factors, and blood type. The onset of ovarian cancer is hidden, and there is a lack of effective early screening methods. When clinical symptoms arise that attract the attention of patients and physicians, it is often in the late stage. At this time, radical surgery is actually difficult to achieve the desired results. According to domestic and international data statistics, the 5-year survival rate of ovarian cancer is still only 25% to 30%. Over the years, experts have conducted many discussions on the treatment plans for ovarian cancer. Currently, the treatment of ovarian cancer includes surgery, chemotherapy, radiotherapy, immunotherapy, biological therapy, and so on. But so far, surgical treatment has been the mainstream treatment for ovarian cancer and has received close attention from people.